Cinctive Capital Management LP

Position in ANNX — Annexon, Inc.

CIK 1787258 New York, NY

Position in ANNX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,488,265

-$313,844 QoQ

Shares Held

268,640

-25.2% QoQ

Ownership

0.135%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Cinctive Capital Management LP holds $185,949,026 across 51 Biotechnology names. ANNX ranks #32 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	73,063	$11,947,261
2	BBIO	BridgeBio Pharma, Inc.	145,728	$10,821,761
3	NTHI	Neonc Technologies Holdings, Inc.	1,425,526	$9,992,937
4	DAWN	Day One Biopharmaceuticals, Inc.	450,000	$9,648,000
5	ACLX	Arcellx, Inc.	80,000	$9,185,600
6	RVMD	Revolution Medicines, Inc.	93,857	$9,127,593
7	SRRK	Scholar Rock Holding Corp	172,535	$8,481,820
8	MDGL	Madrigal Pharmaceuticals, Inc.	15,326	$8,022,701

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,488,265	268,640	-25.2%	Shares	Sole	2026-05-15
2025-12-31	$1,802,109	358,986	+448.4%	Shares	Sole	2026-02-17
2025-09-30	$199,671	65,466	-51.7%	Shares	Sole	2025-11-14
2025-06-30	$325,118	135,466	0.0%	Shares	Sole	2025-08-14
2025-03-31	$261,449	135,466	0.0%	Shares	Sole	2025-05-15
2024-12-31	$694,940	135,466	-27.5%	Shares	Sole	2025-02-12
2024-09-30	$1,106,021	186,828	-14.3%	Shares	Sole	2024-11-14
2024-06-30	$1,068,641	218,090	+392.3%	Shares	Sole	2024-08-14
2024-03-31	$317,631	44,300	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.